Capital Impact Advisors, LLC - SYNTA PHARMACEUTICALS CORP ownership

Back to all holdings Add to watchlist

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 91 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2015. The put-call ratio across all filers is 2.10 and the average weighting 0.9%.

Links
Filings
External links
Quarter-by-quarter ownership
Capital Impact Advisors, LLC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2014$100,000
-12.3%
37,7880.0%0.05%–
Q3 2014$114,000
-26.5%
37,7880.0%0.00%
-100.0%
Q2 2014$155,000–37,788–0.12%–
 Download
Other shareholders

There were no reported owners of SYNTA PHARMACEUTICALS CORP in Q1 2015.

NameSharesValueWeighting ↓
View complete list of SYNTA PHARMACEUTICALS CORP shareholders